Patent attorney Jay Halt explains how medtech companies should align IP strategy with FDA compliance to avoid unenforceable patents and regulatory issues.
Successful U.S. Navy field trials of Menlo’s MEMS-based 1,000-V, 12-A smart circuit-breaker modules validate how they can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results